CAS 153559-49-0|Bexarotene
| Common Name | Bexarotene | ||
|---|---|---|---|
| CAS Number | 153559-49-0 | Molecular Weight | 348.478 |
| Density | 1.0±0.1 g/cm3 | Boiling Point | 489.7±44.0 °C at 760 mmHg |
| Molecular Formula | C24H28O2 | Melting Point | 230-231ºC |
| MSDS | ChineseUSA | Flash Point | 229.5±23.1 °C |
Names
| Name | bexarotene |
|---|---|
| Synonym | More Synonyms |
Bexarotene BiologicalActivity
| Description | Bexarotene is a selective retinoid X receptors (RXR) agonist for the treatment of cutaneous T-cell lymphoma. |
|---|---|
| Related Catalog | Signaling Pathways >>Autophagy >>AutophagySignaling Pathways >>Metabolic Enzyme/Protease >>RAR/RXRResearch Areas >>Cancer |
| References | [1]. Vakeva L, Ranki A, Hahtola S.Ten-year experience of bexarotene therapy for cutaneous T-cell lymphoma in Finland.Acta Derm Venereol. 2012 May;92(3):258-63. doi: 10.2340/00015555-1359. [2]. Zhang X, Schlaak M, Fabri M, Mauch C, Kurschat P.Successful Treatment of a Panniculitis-Like Primary Cutaneous T-Cell Lymphoma of the α/β Type with Bexarotene.Case Rep Dermatol. 2012 Jan;4(1):56-60. [3]. Orendas P, Kubatka P, Kajo K, Stollarova N, Kassayova M, Bojkova B, Pec M, Nosal V, Kiskova T, Zihlavnikova K, Karsnakova R.Melatonin enhanced bexarotene efficacy in experimental mammary carcinogenesis.Neoplasma. 2012;59(4):469-74. [4]. Cras A, Politis B, Balitrand N, Darsin-Bettinger D, Boelle PY, Cassinat B, Toubert ME, Chomienne C.Bexarotene via CBP/p300 induces suppression of NF-κB-dependent cell growth and invasion in thyroid cancer.Clin Cancer Res. 2012 Jan 15;18(2):442-53. [5]. Gui Y, et al. Bexarotent attenuated CCI-induced spinal neuroinflammation and neuropathic pain by targeting MKP-1. J Pain. 2019 Jan 17. pii: S1526-5900(18)30607-2. |
Chemical & Physical Properties
| Density | 1.0±0.1 g/cm3 |
|---|---|
| Boiling Point | 489.7±44.0 °C at 760 mmHg |
| Melting Point | 230-231ºC |
| Molecular Formula | C24H28O2 |
| Molecular Weight | 348.478 |
| Flash Point | 229.5±23.1 °C |
| Exact Mass | 348.208923 |
| PSA | 37.30000 |
| LogP | 8.55 |
| Vapour Pressure | 0.0±1.3 mmHg at 25°C |
| Index of Refraction | 1.556 |
| InChIKey | NAVMQTYZDKMPEU-UHFFFAOYSA-N |
| SMILES | C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C |
Safety Information
| Hazard Codes | Xn |
|---|---|
| RIDADR | NONH for all modes of transport |
Articles18
More Articles| Retinoids Bias Integrin Expression and Function in Cutaneous T-Cell Lymphoma. J. Invest. Dermatol. 135 , 2102-8, (2015) Cutaneous T-cell lymphoma (CTCL) is a heterogeneous group of malignancies characterized by accumulation of malignant T-cells within the skin. Retinoids, metabolic derivatives, and synthetic analogs of... | |
| RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment. Neurobiol. Dis. 82 , 132-40, (2015) We have recently demonstrated that short term bexarotene treatment of APP/PS1 mice significantly improves their cognitive performance. While there were no changes in plaque load, or insoluble Aβ level... | |
| Retinoid X receptors orchestrate osteoclast differentiation and postnatal bone remodeling. J. Clin. Invest. 125(2) , 809-23, (2015) Osteoclasts are bone-resorbing cells that are important for maintenance of bone remodeling and mineral homeostasis. Regulation of osteoclast differentiation and activity is important for the pathogene... |
Synonyms
| Targretin |
| Bexarotene |
| 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl]benzoic acid |
| LG 69 |
| 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthalenyl)vinyl]benzoic acid |
| Lg 1069 |
| 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-vinyl]-benzoic acid |
| Targretyn |
| Bexaroten |
| Targret |
| Benzoic acid, 4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]- |
| 4-[1-(3,5,5,8,8-Pentamethyl-2-5,8-dihydronaphthyl)vinyl]benzoic acid |
| 4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethenyl]benzoic acid |
| LGD1069 |
